Anthony Hunt - 05 Dec 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role: Director
Signature: /s/ Marc Baumgartner (Attorney in Fact)
Issuer symbol: RGEN
Transactions as of: 05 Dec 2024
Net transactions value: +$399,937
Form type: 4
Filing time: 05 Dec 2024, 20:26:45 UTC
Previous filing: 22 Nov 2024
Next filing: 10 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RGEN	Common Stock	Options Exercise	$399,937	+11,808	+8.4%	$33.87	151,648	05 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RGEN	Stock Option (Right to Buy)	Options Exercise	$0	+11,808		$0.000000	8,856	05 Dec 2024	Common Stock	11,808	$33.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	11,808 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2025, 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027.